key: cord-0257947-ee575czs
authors: Neumeier, Daniel; Yermanos, Alexander; Agrafiotis, Andreas; Csepregi, Lucia; Chowdhury, Tasnia; Ehling, Roy A; Kuhn, Raphael; Roberto, Raphaël Brisset-Di; Di Tacchio, Mariangela; Antonialli, Renan; Starkie, Dale; Lightwood, Daniel J; Oxenius, Annette; Reddy, Sai T
title: Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells
date: 2021-07-16
journal: bioRxiv
DOI: 10.1101/2021.07.16.452687
sha: 8a01f87cf5caee4223e69b3d4cc9c90383ab2b2b
doc_id: 257947
cord_uid: ee575czs

The capacity of humoral B cell-mediated immunity to effectively respond to and protect against pathogenic infections is largely driven by the presence of a diverse repertoire of polyclonal antibodies in the serum, which are produced by plasma cells (PCs).1,2 Recent studies have started to reveal the balance between deterministic mechanisms and stochasticity of antibody repertoires on a genotypic level (i.e., clonal diversity, somatic hypermutation, germline gene usage).3–8 However, it remains unclear if clonal selection and expansion of PCs follows any deterministic rules or is stochastic with regards to phenotypic antibody properties (i.e., antigen-binding, affinity, epitope specificity). Here we report on the in-depth genotypic and phenotypic characterization of clonally expanded PC antibody repertoires following protein immunization. We find that there is only a strong correlation with antigen-specificity among the most expanded clones (top ~ 10), whereas among the rest of the clonal repertoire antigen-specificity is stochastic. Furthermore, we report both on a polyclonal repertoire and clonal lineage level that antibody-antigen binding affinity does not correlate with clonal expansion or somatic hypermutation. Lastly, we provide evidence for convergence towards dominant epitopes despite clonal sequence diversity among the most expanded clones. Our results highlight the extent to which clonal expansion can be ascribed to antigen binding, affinity and epitope specificity and they have implications for the assessment of effective vaccines. Graphical abstract

Humoral immunity and successful vaccination require the generation of sustained levels of circulating serum antibodies, 9 which are produced by clonally expanded PCs, a terminally-differentiated subset of B cells that reside in lymphoid organs (e.g., bone marrow) for an extended period of time (up to years for mice and humans). 1, 10, 11 This dynamic process involves the recombination of germline-encoded genetic elements that encode the antibody [or B cell receptor (BCR)] in single B cells; 12 dogma holds that B cell clonal selection, iterative expansion, and differentiation to PCs occurs for clones with increased affinity towards the antigen. [13] [14] [15] [16] [17] [18] While there have been numerous studies describing how this process is orchestrated on the genotypic level in several species (e.g., humans, mice and zebrafish), 3, 4, 6, [19] [20] [21] much less is known about the associated phenotypic antibody repertoire metrics comprising features such as antigen-binding, [22] [23] [24] [25] quantitative binding affinity and epitope specificity, which can physically be measured as a consequence of the antibody amino acid (a.a.) sequence composition. Importantly, most of the studies reporting phenotypic antibody repertoire data were confined to memory B cells or short-lived plasma blasts that express surface BCR, and in contrast to PCs, do not secrete large amounts of antibody proteins [immunoglobulin (Ig)]. [22] [23] [24] [26] [27] [28] [29] [30] Previous studies on vaccine-induced PC repertoires (murine-and bone marrow-derived) have found that they are dominated by a few (~ 3 -5) highly expanded clones that are antigen-specific, 19, 31 which correlates with the observation that up to 60 -90% of the total antigen-specific IgG serum repertoire is comprised of only a few clones (~ 4 -12). [32] [33] [34] However, it remains unclear whether any deterministic factors such as antigen affinity or epitope specificity drive the selection of these highly expanded clones, and how deep antigen specificity tracks within the PC repertoire. Previous results obtained from adoptive B cell transfer and immunization experiments in BCR transgenic mouse models (monoclonal antibody knock-ins) revealed that high affinity BCRs promote early splenic B cells to differentiate to PCs, 35, 36 a phenomenon that was also reported in a more recent study. 37 However, contrasting work showed that instead of PC differentiation, the onset of which was later found to occur during late germinal center reactions, 38 higher BCR affinity led to increased overall proliferation of antigen-reactive cells. 39 Therefore, it remains unclear how transferable phenotypic antigen binding data from B cells of isolated germinal centers or individual lymph nodes 40, 41 are for the development of long-lived PC repertoires. Here, we set out to comprehensively address these long-standing questions of clonal selection and expansion of PCs. We developed an integrative genotype-phenotype mapping approach and applied it for the in-depth characterization of clonally expanded PC antibody repertoires across five immunized mice.

We used single-cell sequencing and computational analysis of antibody repertoires combined with quantitative antibody-antigen-binding, -affinity, epitope-binning and -mapping measurements (Fig. 1a) which resulted in the characterization of >230 antibodies (which constitute ~ 50% of all captured PCs (IgG) per repertoire). To this end, we repeatedly immunized five BALB/c mice subcutaneously with the T cell-dependent model antigen ovalbumin (OVA) in monophosphoryl lipid A (MPLA) adjuvant. PCs were isolated (based on CD138 + B220 low/-CD19 low/surface expression) from bone marrow two weeks after the final boost, which represents the peak of PC homing to the bone marrow 42, 43 (Fig. 1a) . Next, targeted single-cell sequencing was performed on uniquely barcoded heavy and light chain transcripts, covering all Ig isotypes (10X Genomics V(D)J protocol) (Extended Data Fig. 1a ). After quality filtering and bioinformatic removal of multiplets, we obtained sequence data on thousands of PCs for each mouse (1891 -7859 cells) with one paired full-length variable heavy-(VH) and variable light-(VL) chain sequence (Extended Data Fig. 1b) , which translated to 672 -1657 distinct clones (a clone being defined as a unique CDRH3-CDRL3 a.a. sequence) per mouse (across all isotypes) (Fig. 1b,   Extended Data Fig. 1c) . To characterize the state of clonal expansion for each repertoire, we operated under the assumption that since the murine naïve BCR sequence diversity (10 13 ) 6 far exceeds the steady-state number of PCs in the bone marrow of a given mouse (~7.5x10 4 ), 43 detecting two or more cells with the same clonal CDRH3-CDRL3 sequence could be used to define clonal expansion (irrespective of isotype origin). 44, 45 We found 199 -1007 clones to be expanded for each mouse repertoire (30 -61% of all clones per repertoire), whereas a substantial proportion of clones was detected only once (Fig. 1b) . Furthermore, all PC repertoires were reproducibly dominated by highly expanded IgM clones (Fig. 1c, Extended Data Fig. 2) , some of which made up almost 8% of the total cellular repertoire count (IgM-1). As expected, the mutational load between isotypes differed significantly when the 30 most expanded clones per isotype were compared, with most of the IgM clones featuring only a single a.a. intraclonal variant, whereas the number of intraclonal variants markedly increased for expanded IgA and IgG clones (Fig. 1d, Extended Data Fig. 2b, 3) . Interestingly, when we tested six of the most expanded IgM clones of a single mouse, some of which were also shared between mice, we did not observe any detectable binding to the OVA antigen (or MPLA adjuvant) (Fig. 1e, Extended Data Fig.   4 ). Likewise, when we screened five of the most expanded IgA clones of the same mouse, no antigen-binding was detected (Fig. 1f, Extended Data Fig. 5) . Therefore, we focused our analysis on the expanded IgG compartment and determined the antigen specificity [by enzyme-linked immunosorbent assay (ELISA)] of the 50 -60 most expanded antibody clones from mouse (MS) -1, -2 and -5 (which were chosen based on their respective sequencing depth), along with 15 of the most expanded clones from MS-3 and -4 (Extended Data Fig. 6a, b) . Together, these clones represented 50 -54% of total IgG cells per mouse for MS-1, -2, and -5 and overall, we found that between 42% and 48% of clones per mouse were antigen-specific (Extended Data Fig.   6a ; 60% for MS-3 and MS-4). While the most expanded five to ten clones per repertoire were usually antigenspecific, across the rest of the repertoire, antigen-binding and non-binding clones were evenly distributed (Fig.   1g ). In light of this high degree of stochasticity, we determined how deep antigen-specificity tracks into the repertoire by testing a set of 15 randomly chosen IgG clones from MS-1, including clones that had a cell count as low as one. Even this deep into the repertoire, several clones corresponding to IgG clone rank 249 -404 and total clone rank 1008 -1657 showed detectable antigen-binding (Fig. 1h, Extended Data Fig. 6c, d) .

Next, given the context of a polyclonal, multi-epitope directed antibody repertoire, we investigated if clonal expansion of PCs is driven by the affinity to the cognate antigen. To this end, we used biolayer interferometry (BLI) to measure the affinity [apparent equilibrium dissociation constants (KD)] of 55 antigen-specific IgG clones from MS-1, -2, and -5, resulting in a wide range of affinities (KD = 2 -450 nM) (Extended Data Table 1 ). This revealed that there was no direct correlation between clonal expansion (based on cell count of a clone) and antigen affinity, as highly expanded clones (cell count > 20) were just as likely to have moderate (KD ~ 100 -450 nM) or high (KD ~ 10 -100 nM) affinities, including the surprising observation that the highest affinity (KD < 10 nM) clones often had low cell counts (<10) (Fig. 2a) . Likewise, we observed highly expanded clones with significantly disparate affinities, as exemplified by the two most expanded clones of MS-5 (5.1 and 5.2), which displayed KD values of 18.7 nM and 451.8 nM, respectively (Extended Data Table 1 ). Moreover, we did not observe a direct link between antibody-antigen affinity and the extent of somatic hypermutation, neither on the a.a. (Fig. 2b) nor on the nucleotide (nt) level (Extended Data Fig. 7) . In some cases, clones that were closer to germline such as the fourth most expanded clone of MS-5 (5.4, 7 a.a. mutations) exhibited high affinity (KD = 8.8 nM), whereas in comparison a highly mutated and highly expanded clone (5.1, 16 a.a. mutations) had a lower affinity (KD = 18.7 nM) (Extended Data Table 1 ). For some antigens, such as influenza hemagglutinin and the spike protein of SARS-CoV-2, it has been shown that certain germlines are structurally predisposed for antigen-specificity and high affinity. [46] [47] [48] Therefore, we determined whether VH-VL germline gene (IGHV-IGKV) combinations impacted the affinity of a given antibody to OVA. For the 31 antigen-specific germline combinations tested, some of which shared the same VH or VL genes, we found that affinity was independent of germline gene usage. Most affinities fell into the same range and in case of multiple data points per VH-VL combination, the standard deviation for affinity could span a large range (KD ± 250 nM) (Fig. 2c) . Next, we determined if certain VH-VL germline combinations were enriched in the antigen-binding or non-binding fraction of the tested clones. Analysis of VH-VL germline gene usage by circos plots of the 79 experimentally verified antigen-binding and 95 non-binding clones did not show enrichment for certain germline combinations in either of the two groups (Fig. 2d) . Next, we performed a sequence-similarity network analysis (CDRH3-CDRL3 sequence nodes connected by < 4 a.a. difference) 49 Fig. 8, Fig. 2e) , which harbored clusters of both antigen-binding and nonbinding clones, highlighting the potential importance of key amino acid sequence motifs beyond the CDRH3-CDRL3 that contribute to antigen specificity. 50 To evaluate whether there were any other features that separate antigen-binding from non-binding clones, we further analyzed common metrics such as distance to germline, number of intraclonal sequence variants, and CDRH3/CDRL3 length and found that only the number of distinct intraclonal antibody sequence variants was significantly increased for antigen-binding clones (Extended Data Fig. 9 ). Upon closer examination of Ig isotype (IgM, IgA) and IgG subtype (IgG1, 2b, 2c, 3), we observed a consistently higher percentage of IgG1 cells among the antigen-binding fraction of clones (Fig. 2f) . When we tested seven clones that were composed of several isotypes (with minimal to no IgG1), none of them showed detectable antigen binding, suggesting that multi-Ig class-switch recombination does not correlate with antigen specificity (Fig. 2g , Extended Data Since we established that within the context of the polyclonal repertoire, selection of highly expanded clones was not driven by antigen binding affinity, we next sought to determine the relationship between antigen affinity and clonal expansion within the evolutionary trajectory of a clonal lineage (PCs sharing identical V-and Jgenes and identical CDRH3-CDRL3 sequences). We thus expressed antibodies and measured affinities for the most expanded IgG clonal lineage of MS-1, which featured 29 intraclonal sequence variants distributed across a total of 227 cells (Fig. 3a, Extended Data Fig. 11 ). We observed no direct correlation between expansion of an intraclonal sequence variant and binding affinity to antigen. Moreover, the number of somatic hypermutations (distance to germline) did not correlate with affinity and intraclonal variants with lower affinity (KD > 15 -50 nM) generally originated from earlier ancestral branch points of the lineage tree ( Fig. 3b-d,   Extended Data Fig. 12 ). This provides further evidence for the existence of a clonal physiological affinity ceiling, as has been proposed in previous work, 24, 51 and which falls within the range of affinities (KD = 2 -450 nM) measured for polyclonal antibodies (Fig. 2c) .

Next, we investigated whether clones derived from different mice that shared highly similar sequences (identical V-and J-genes, CDRH3-CDRL3 with < 5 a.a. difference) show similar antigen binding behavior (Extended Data Fig. 13 ). Nine clones were tested, which were similar to a previously identified antigenspecific clone (5.17) and showed consistently similar affinities (KD = 4 -26 nM) ( Fig. 3e-g; Extended Data   Fig. 13 ). Next, we examined a major cluster of a sequence similarity network that contained 129 sequence nodes and 32 unique VH-VL germline combinations (CDRH3-CDRL3 sequence nodes connected < 4 a.a. difference). Of those, four clones with different germline genes were randomly selected and we could confirm antigen binding for three of them ( Fig. 3h-j) .

Finally, we aimed to understand the epitope specificity and targeting space of expanded PC clones. Using BLI, we first performed cross-competition epitope binning experiments with highly expanded antibody clones that possessed moderate to high affinity (KD ~ 3 -165 nM). This revealed that within a given mouse, a majority of clones could be grouped into discrete epitope bins ( Fig. 4a , b, Extended Data Fig. 14) . Next, when we tested competitive binding of clones originating from across the different mice (MS-1, -2 and -5) (Extended Data Fig.   15a ), three dominant epitope bins emerged, some of which contained clones from all mice (bin 1 and 3), whereas others were mainly occupied by clones from a single mouse (bin 2) (Fig. 4c) . For clones 1.12 and 5.1 (the most expanded clone of MS-5) we did not observe any competitive binding suggesting that they target unique epitopes compared to all other clones tested. Interestingly, we observed a number of different VH-VL germline gene combinations for each bin (Fig. 4c, Extended Data Fig. 15b ). Clonal diversity in each bin was also observed (based on CDRH3-CDRL3 sequences) (Fig. 4d ) and when we mapped the bin epitope space of the expanded clones on to the complete IgG clonal sequence similarity network (CDRH3-CDRL3 sequence nodes connected < 4 a.a. difference), we could clearly observe epitope convergence despite a high degree of sequence diversity (Fig. 4e) . This was particularly evident for the biggest sub-network (containing 32 different VH-VL combinations) which exclusively harbored clones of epitope bin 1. Phenotypically, we again did not observe a correlation between clone affinity and epitope specificity when affinity data from different mice per bin were compared (Extended Data Fig. 15c) .

In order to more precisely define epitope specificity in relation to the sequence and structure of the OVA antigen, we used a bacterial linear peptide display system, 52 where an overlapping 15-mer (a.a.) peptide library of the primary antigen sequence is expressed on the surface of E. coli. Highly expanded antibody clones are then used to label the antigen peptide library and sequential rounds of fluorescence-activated cell sorting (FACS) is performed to enrich for peptide binding, followed by targeted deep sequencing of peptide encoding regions. Subsequently, epitopes are identified using sequence-alignment and read count statistics (Fig. 4f) .

To benchmark the system, we used two commercial monoclonal antibodies with well-defined OVA-specificity for which we could successfully confirm their respective epitopes (Extended Data Fig. 16 ). We then determined the epitopes of nine highly expanded clones across the different mice (MS-1, -2 and -5) (Fig. 4g,   Extended Data Fig. 17 ). For all clones (except 2.4 and 5.14, for which only a single highly enriched peptide was found to bind the antibody), FACS enrichment followed by read count analysis resulted in a small number (3 -12) of overlapping peptide sequences that were highly enriched compared to the background. Within those, we defined the peptide sequence with the highest read count enrichment (observed 86 -56,000-fold above background) as the corresponding epitope. Importantly, we identified the same epitope for two clones (2.4 and 2.24) sharing highly similar sequences (identical VHJH-VLJL germline, CDRH3-CDRL3 edit distance of 4 a.a.).

Finally, several of the clones were also representative of the identified epitope bins (Fig. 4c) , for example clones 1.15, 1.17 and 2.4/2.24, allowing us to precisely map these bins onto the structure of the OVA antigen, which revealed that they were indeed occupying distinct areas of the antigen (Fig. 4h) .

Here, we set out to determine if clonal selection and expansion of PC repertoires follows any deterministic rules or is stochastic with regards to their phenotypic antibody properties (i.e., antigen-binding, -affinity, epitope specificity). First, we discovered that except for the most expanded clones (~ top 10), antigen specificity was largely stochastic and could not be predicted based on the number of expanded cells (Fig. 1g) .

Next, we determined if PC repertoire affinities allowed for accommodating the widely accepted germinal center B cell selection model: selective expansion of B cells is driven by an avidity-based selection mechanism in germinal centers involving high-affinity BCRs expressed on B cells that consequentially present the highest levels of peptide-MHC to T follicular helper cells, 41, 53, 54 which in turn controls the rate of B cell proliferation. 55 In contrast to this model, we did not observe any deterministic correlation between antibody affinity and clonal expansion of PCs, furthermore affinity was also not correlated with the number of somatic hypermutations; these stochastic findings were consistent both on the polyclonal repertoire level (Fig. 2a, b) and the clonal lineage level (Fig. 3c, d) .

While we acknowledge that our experimental setup reflects the collective PC-differentiated integration of multiple germinal center outputs that to some extent mirror ongoing (primarily) naïve B cell engagement, 56 similar results have been observed recently for differentially expanded germinal center B cells. 40 Therefore, we speculate that over time avidity-based selection may not only be a consequence of affinity alone, but for example can also lead to autoantibody redemption via somatic hypermutation. 57 Furthermore, from a B cell's perspective, capturing of antigen may further be modulated by differential BCR stability and surface expression levels, which can also be fine-tuned by somatic hypermutation. To illustrate, recent work has suggested that somatic hypermutation is associated with decreased conformational antibody stability. 58 Furthermore, highly differential antibody secretion rates from single plasma cells have been reported, which can span up to 3 -4 log units. 59 It remains to be determined how these findings translate to surface expression levels of germinal center B cells and subsequent clonal selection, expansion and differentiation to PCs.

Finally, our results also indicate that despite a high level of antibody sequence diversity, the selection of PCs has a deterministic component with regards to specificity towards a few dominant epitopes, which may be attributed to epitope accessibility and availability during B cell maturation and PC differentiation (Fig. 4c-e) .

This could also provide a rationale for the shifting serum epitope immunodominance hierarchies over time, as observed following influenza A virus infection. 60 Collectively, our findings highlight the fine balance between stochastic and deterministic phenotypic feature selection in differentiated PC repertoires, which only in concert drive clonal selection and expansion. This work has implications for the assessment of vaccine-induced immunity, as understanding how the distribution profile of desired PC clones can be modulated, may support the development of vaccines that provide broad and long-lasting protection by the humoral immune system.

Mouse immunizations were performed under the guidelines and protocols approved by the Basel-Stadt 

Raw sequencing files arising from multiple Illumina sequencing lanes were merged and supplied as input to the command line program cell ranger on a high-performance cluster. Reads were aligned to the germline using cellranger (v3.1.0) segments from the murine VDJ reference (vdj_GRCm38_alts_ensembl-3.1.0) and subsequently assigned into clonal families based on identical combinations of CDRH3+CDRL3 amino acid sequences. Only those clones containing exactly one productive heavy chain and one productive light chain were retained in the analysis. Isotype majority was determined based on the constant region alignment containing the within each clonal family, with all IgG subtypes merged. Full-length variable sequences (spanning from FR1 to FR4) for each cell were obtained by using the call_MIXCR function in Platypus, 61 which relies upon aligning full-length contig sequences from the all_contig.fasta file output from cellranger using MiXCR. 62 To quantify unique variants, full-length VDJRegion (defined as FR1-FR4) for both heavy and light chains were appended together for each cell. Similarity networks were created by calculating the pairwise edit distance using the stringdist package 63 in R and subsequently creating an adjacency matrix, where each entry (node) corresponded to a unique CDRH3+CDRL3 nucleotide sequence (network shown in Fig. 2e was created based on unique CDRH3+CDRL3 a.a. sequence). Edges were drawn between nodes with an edit distance of three or less amino acid mutations and following networks were created by R package igraph.

Edit distances were calculated using the stringdist package. Circos plots demonstrating germline gene usage were created using the circlize package 64 in R. The unmutated germline reference gene was determined by Cellranger's alignment and set as the outgroup for the phylogenetic tree. Nucleotide and amino acid distance to germline was determined via IMGT. 65

Antibodies were either transiently expressed at small scale in HEK 293 Expi cells using the ExpiFectamine 293 Transfection Kit (Thermo, A14524) and the pFUSE2ss vector system for both, IgM/IgK and IgG/IgK/L (Invitrogen) according to previous protocols, 66 or stable hybridoma cell lines were engineered by CRISPR/Cas9 genome editing as described before. 67, 68 Of note, these hybridoma cell lines are able to surface display as well as secrete antibody of the IgG2c isotype, which allows for both, FACS-based as well as ELISAbased specificity profiling. Fig. 1 and 2 , each of the steps was timed to last equally long. 

Bacterial epitope mapping was based on the pB33eCPX plasmid, which was previously established 52 to fuse a peptide to the enhanced outer membrane protein X (OmpX) for extracellular peptide presentation. First, we modified the plasmid using primers EpMap_1 and EpMap_2 along with ssODN EpMap1_ssODN (Extended Data Table 3 ) using the NEBuilder Mastermix (NEB, E2621S) following the manufacturer's instructions in order to create hairpin-free overlap regions that could be used for homology-based library cloning. Next, the epitope library was generated using MC1061 E. coli cells, NEBuilder Mastermix, primers EpMap_3 and EpMap_4 (Extended Data Table 3 primer EpMap_5, we found that 95% contained a correct sequence of which 95% were unique. Glycerol stocks were subsequently stored at -80 °C until further use.

Bacterial display-based epitope mapping was carried out as described before. 69 Briefly, 500 ml of LB-medium supplemented with chloramphenicol (34 μg/ml) and 0.2% (w/v) 0.2 μm sterile filtered glucose were inoculated with the transformant library and grown for 12 hours at 37 °C. Next, cells were subcultured 1:50 into 5 ml of LB supplemented with chloramphenicol and grown for 2 hours at 37 °C, before protein expression was induced for 1 hour at 37 °C using 0.04% (w/v) L-arabinose. Typically ~1.1E7 cells were subsequently Cells were again washed twice, resuspended in 500 μl of PBS and sorted into sterile SOC media using a BD FACS Aria III. Typically, between 10,000 and 50,000 cells were sorted on 2 -3 consecutive days to enrich for pure antigen-binding populations, before plasmid was extracted and sequencing libraries were generated.

Bacterial plasmid DNA was extracted from a 3 ml overnight culture using the QIAprep Spin Miniprep Kit (Qiagen, 27104). Next, NGS libraries were generated following a two-step primer extension protocol. 70 Sensitivity NGS fragment analysis kit prior to sequencing. High-quality library pools were sequenced on the Illumina MiSeq platform using the reagent kit v3 (2x300 cycles, paired-end) with 10% PhiX.

Forward and reverse reads were merged in Geneious v10.2.6 and subsequently read into R (v.4.0.4) using the 'read.fasta' function from the 'seqinr' package. The number of occurrences of each epitope within these reads was determined using the 'str_count' function from the 'stringr' package.

FACS plots were created using FlowJo v10 (BD). Sequence alignments, phylogenetic trees and logo plots were exported from Geneious v10.2.6. Structural epitope visualization was performed using Pymol v2.4.2.

BLI affinity traces were exported from Data Analysis HT v11.0.0.50 (FortéBio). Fig. 1a and 4f were created with BioRender.com. The generation of all other figures was either already described or they were produced using Prism v8 (Graphpad). Left: Flow cytometry histogram plot shows ovalbumin (OVA) labeling of hybridoma cell lines with stable surface expression of selected antibody clones (from IgM or IgA PCs) or expression of positive or negative controls (antibodies with defined binding to OVA (PC, orange) or to hen egg lysozyme (NC, dark grey)). Right: heatmaps indicate antibody expression and binding to OVA based on endpoint ELISA (data obtained from Extended Data Figure 4d and 5b) . g. Antigenspecificity profiling of the top 50-60 expanded clones of MS-1, -2 and -5. Clones with an endpoint ELISA signal >0.2 (three-fold above background) are designated as antigen binders (see also Extended Data Figure  6a ). h. Antigen-specificity of clones showing lower to no clonal expansion (cell count = 1, red dotted line) from MS-1. Similarity network plot for all 174 antigen-binders and non-binders tested across all mice. Edges represent clones separated by edit distance of < 4 a.a. in CDRH3-CDRL3 sequences. Extent of clonal expansion is reflected by the size of the nodes. Annotated labels of each node are according to clone ID in Extended Data Table 1 and 2. f. Cellular isotype fractions for all binders (B) and non-binders (NB) per mouse. g. Validation of multi-isotype clones by hybridoma surface staining and ELISA screening. Left and middle: flow cytometry histograms and heatmaps similar to as shown in 1e, f. (ELISA data shown in Extended Data Figure 11 ). Right: cellular isotype composition of each clone and associated nt distance from germline. Error bars indicate standard deviation (n = 3-5 measurements of KD). d. Correlation between KD and amino acid distance to germline. Error bars indicate standard deviation (n = 3-5 measurements of KD). e. Phylogenetic lineage tree of clones originating from several mice that have similar sequences (identical Vand J-genes, CDRH3-CDRL3 with < 5 a.a. difference) (see also Extended Data Fig. 13a-c) . Branch colors reflect mouse ID from a. and node sizes reflect clone size. f. Flow cytometry histograms for OVA binding, similar to 1e, 2f. GL denotes germline, clones correspond to lineage tree shown in e. g. Heatmap shown is similar to 3b. h. Network plots of connected IgG sequence nodes from all mice harboring various VH-VL gene combinations. Edges represent clones separated by edit distance of three or less a.a. based on the concatenated CDR3 sequences. Left: verified binders, non-binders, not tested clones as well as newly chosen clones are shown. Clone ID according to Extended Data Table 1 Red indicates no binding of the probe antibody as a consequence of epitope blocking by the capture antibody, whereas green denotes binding of the competitor antibody. Groups of antibodies that target the same epitope (epitope bins) are highlighted in white squares. Brackets indicate clonal variants that share the same VH/VL germline V-genes which differed only in CDRH3/CDRL3 a.a. sequence. An anti-RSVF capture antibody, which does not bind the antigen was used as negative control for all experiments. Clone ID according to Extended Data Table 1 . b. Epitope bins with associated clones as determined in a. Nodes are connected based on observed direct cross-competition. c. Epitope bins as defined by the cross-competition of clones from different mice. Representative V-gene combinations are shown on the right. Nodes are connected based on direct cross-competition and sizes indicate clone size (number of cells per clone). Colors represent mouse ID as shown in b. Results are reflective of Extended Data Fig. 16 . d. CDRH3/CDRL3 sequence alignment of bin-specific clones. Sequence logo is shown on top and a.a. residues are highlighted if they are in disagreement with the consensus sequence. e. Mapping of epitope space as determined in c on a sequence similarity network of all IgG clones across all mice (Extended Data Fig. 9 ). Edges represent clones with < 4 a.a. difference in CDRH3-CDRL3 sequence. Node color according to bin color in c. Size of clones is reflected by node size. Only those nodes with at least one edge are plotted for visualization purposes. Clone 1.20 is not shown since it was not connected. f. Linear epitope-mapping workflow using bacterial peptide display. g. Epitope mapping results of select clones from MS-1, -2 and -5. For visualization purposes, only data points with >700 mapped reads are shown for MS-1 and -2 and clone 5.14 of MS-5; for clones 5.12 and 5.29 only data points with >18 mapped reads are shown. Shared data point between 5.12 and 5.29 is indicated with a circle. Corresponding V-gene combinations are indicated. Separate scatter plots featuring all data points are provided in Extended Data Fig. 18 . h. Mapping of epitope bins from c on to the OVA crystal structure using antibody epitope information obtained in g (PDB: 1OVA).

(IgA) respectively. Pie-chart inlet indicates the numbers of isotype clones among the top 50 clones shown. b. Clonal expansion profiles indicating all clonal amino acid sequence variants per clone and their respective isotype assignment. Separate clonal sequence variants are shown in stacked bar plots ordered by their respective size from bottom to top. Whenever a smaller sized bar of different isotype origin intersects two bigger bars, this indicates that these cells belong to the clonal variant below. Coloring scheme according to a with unassigned isotype cells shown in white. Extended Data Figure 6 . Profiling of top and low expanded IgG clones per mouse. a. ELISA profiling results of all top expanded clones tested per mouse. Clones were denoted binders if ELISA signal was >0.2 (3-fold above background; red dotted line). Binders are shown in orange, whereas clones that did not bind OVA or could not be expressed are shown in green and grey respectively. b. Overview of tested top expanded clones of MS-3 and -4. + denotes ELISA signal >0.2. c. ELISA profiling results of all low expanded MS-1 clones tested. d. Table indicating binding of low expanded clones as well as number of cells and corresponding IgG and total clone ranks within MS-1 repertoire. Figure 7 . Correlation between apparent dissociation constant (KD App ) and nucleotide distance to germline of clones shown in Fig. 2a, b. Extended Data Figure 8 . IgG similarity network. Global IgG similarity network plot for all IgG clones across all mice. Edges represent sequence nodes separated by edit distance of less than four a.a. Only those nodes with at least one edge are plotted for visualization purposes. Clones from different mice are indicated in different colors respectively. Extent of clonal expansion per clone is reflected by the size of the nodes. Figure 10 . ELISA screening of multi-isotype clones shown in Fig. 2g . Sandwich ELISA results of 3-fold serially diluted stable hybridoma cell culture supernatant of engineered cell lines expressing selected clones as IgGs. Plots on the left indicate IgG expression levels and plot on the right shows binding to OVA. For each sample, two technical replicates were analysed and a four-parameter logistical curve was fitted to the data by nonlinear regression. Data are presented as the mean (n = 2 measurements) and error bars indicate standard deviation. Supernatant of a HEL specific hybridoma cell line served as negative control (NC, black) and supernatant of an OVA specific inhouse cell line was used as positive control (PC, orange). Figure 16 . Establishment of a bacterial peptide display workflow for linear epitope mapping. a. Quality control of the unselected cloned OVA epitope library by NGS. All 372 peptide 15-mer windows (one amino acid offset) were observed (left) at comparable frequencies (right). Mean window occurrence for the respective NGS run is indicated in red. b. Flow cytometry dot plots show that secondary FACS antibody does not lead to unspecific enrichment after two rounds of enrichment. Unstained denotes no primary antibody. Positive and negative control primary mAb used were OVA specific mAb Clone 2322 (Chondrex, 7094) and an inhouse RSVF specific mouse IgG. c. Assay establishment with two OVA specific antibodies with known epitope specificity. Top: FACS dot plots show FACS enrichment of cells binding to commercial antibodies Clone 2322 (Chondrex, 7094) (left) and Clone 4B4E6 (Chondrex, 7096) (right). Middle: NGS results after one and two rounds of FACS enrichment. Bottom: experimentally determined epitope identity compared to epitope information provided by the manufacturer. Epitope overlap is indicated in bold red. Figure 17 . Epitope mapping results of clones with linear epitope specificity as shown in Fig. 4e . a. Flow cytometry dot plots indicate FACS enrichment of positive clones for each antibody. b. Deep sequencing results of positive FACS output and epitope assignment for each antibody. Numbers correspond to the peptide index that was enriched the most. Only peptides with one or more occurrences are shown.

Humoral immunity due to long-lived plasma cells

Maintenance of serum antibody levels

High-throughput sequencing of the zebrafish antibody repertoire

Determinism and stochasticity during maturation of the zebrafish antibody repertoire

Inferring processes underlying B-cell repertoire diversity

Systems analysis reveals high genetic and antigen-driven predetermination of antibody repertoires throughout B cell development

Commonality despite exceptional diversity in the baseline human antibody repertoire

High frequency of shared clonotypes in human B cell receptor repertoires

Duration of humoral immunity to common viral and vaccine antigens

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans

B cell memory: building two walls of protection against pathogens

Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions

Variations in affinities of antibodies during the immune response

Variability in the lambda light chain sequences of mouse antibody

Intraclonal generation of antibody mutants in germinal centres

A modification of Jerne's theory of antibody production using the concept of clonal selection

Germinal centers

The generation of antibody-secreting plasma cells

Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells

High-resolution antibody dynamics of vaccine-induced immune responses

Large-scale sequence and structural comparisons of human naive and antigenexperienced antibody repertoires

Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination

High-throughput mapping of B cell receptor sequences to antigen specificity

Memory B cell activation, broad anti-influenza antibodies, and bystander activation revealed by single-cell transcriptomics

High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

Infants infected with respiratory syncytial virus generate potent neutralizing antibodies that lack somatic hypermutation

Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput singlecell sequencing of convalescent patients' B cells

Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Facile discovery of a diverse panel of anti-Ebola virus antibodies by immune repertoire mining

Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response

Identification and characterization of the constituent human serum antibodies elicited by vaccination

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes

Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation

High affinity germinal center B cells are actively selected into the plasma cell compartment

Humoral immunity. Apoptosis and antigen affinity limit effector cell differentiation of a single naïve B cell

A temporal switch in the germinal center determines differential output of memory B and plasma cells

Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts

Visualizing antibody affinity maturation in germinal centers

Clonal selection in the germinal centre by regulated proliferation and hypermutation

Bone marrow is a major site of long-term antibody production after acute viral infection

Lifetime of plasma cells in the bone marrow

Linking T-cell receptor sequence to functional phenotype at the single-cell level

Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease

Structural and genetic basis for development of broadly neutralizing influenza antibodies

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients

Large-scale network analysis reveals the sequence space architecture of antibody repertoires

Convergent selection in antibody repertoires is revealed by deep learning

Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate

Directed evolution of a biterminal bacterial display scaffold enhances the display of diverse peptides

Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter

Dynamic signaling by T follicular helper cells during germinal center B cell selection

HUMORAL IMMUNITY. T cell help controls the speed of the cell cycle in germinal center B cells

Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting

Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination

Affinity maturation enhances antibody specificity but compromises conformational stability

Single-cell deep phenotyping of IgG-secreting cells for high-resolution immune monitoring

Defining B cell immunodominance to viruses

Platypus: an open-access software for integrating lymphocyte single-cell immune repertoires with transcriptomes

MiXCR: software for comprehensive adaptive immunity profiling

The stringdist Package for Approximate String Matching

circlize Implements and enhances circular visualization in R

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis

Transient expression of human antibodies in mammalian cells

Immunogenomic engineering of a plug-and-(dis)play hybridoma platform

Antibody discovery and engineering by enhanced CRISPR-Cas9 integration of variable gene cassette libraries in mammalian cells

Peptide discovery using bacterial display and flow cytometry

Comprehensive evaluation and optimization of amplicon library preparation methods for high-throughput antibody sequencing

Total number of paired sequencing reads per mouse (black, left axis) and mean paired sequencing reads per cell (grey, right axis) for all mice. b. Number of all sequenced cells per mouse (black) and number of cells with one productive, full-length heavy-and lightchain pair (grey). c. Number of sequenced productive cells (black) and clones (grey) with isotype resolution for each mouse

Extended Data Figure 2. Clonal expansion profiles for the 50 most expanded clones per mouse. a. Clonal expansion profiles based on isotype majority

Selected metrics for binder-and non-binder pools of clones. a. Left: nucleotide distance to germline for heavy-and light-chain only as well as across heavy-and light-chain combined. Top: ns, not significant (P=0.70); middle: *P=0.02; bottom: ns, not significant (P=0.64); unpaired Student's t-test. Right: amino acid distance to germline for heavy-and light-chain only as well as across heavy-and lightchain combined. Top: ns

Analysis encompassed 174 experimentally verified sequences (79 binder and 95 non-binder) provided in Extended Data Table 1 and 2 respectively. b. Number of intraclonal amino acid sequence variants. *P=0.02, unpaired Student's t-test. Analysis contained all sequences provided in Extended Data Table 1 and 2 except for singlet clones

Top: ns, not significant (P=0.44); middle: ns, not significant (P=0.49); bottom: ns, not significant (P=0.49); unpaired Student's t-test. Analysis encompassed experimentally verified sequences (79 binder and 95 non-binder)

Characteristics of tested intraclonal sequence variants shown in Fig. 3b. a. Characteristics of tested variants. Differences in VL gene usage and CDR3 amino acid sequence as well as sequences coming from different mice are indicated in red. b. Heavy (top) and light-chain (bottom) amino acid sequence alignment of clones with shared V/J genes

Extended Data Figure 12. Correlation between apparent dissociation constant (KD App ) and nucleotide distance to germline. Error bars indicate standard deviation (n = 3-5 measurements of KD)

Characteristics of tested clones shown in Fig. 3e-g. a. Characteristics of tested clones. Differences in CDR3 amino acid sequence are indicated in red. b. Heavy (top) and light-chain (bottom) amino acid sequence alignment of tested clones

Edges represent clones separated by edit distance of three or less based on the concatenated CDR3 aa sequence. Binders, non-binders, not tested clones as well as newly chosen clones are shown in orange, green, black and red respectively

Antibodies indicated on the left were captured and probe antibodies on top were used to determine cross-competition for epitope access. Red indicates no binding of the probe antibody as a consequence of epitope blocking by the capture antibody, whereas green denotes binding of the competitor antibody. Groups of antibodies that target the same epitope (epitope bins) are highlighted in white squares. Brackets indicate clonal variants that share the same VH/VL as well as CDR3 length and only differ in their CDR3 amino acid sequence. An anti-RSVF capture antibody, which does not bind the antigen was used as negative control for all experiments. Clone ID according to Extended Data Table 1. b. Characteristics of bin-specific clones

Extended Data Table 1. Overview and characteristics of OVA binders. Clone ID corresponds to mouse number followed by clone index number corresponding to Fig

Extended Data Table 2. Overview and characteristics of non-binders. Clone ID corresponds to mouse number followed by clone index number corresponding to Fig

Overview and characteristics of non-binders. Clone ID corresponds to mouse number followed by clone index number corresponding to Fig

Extended Data Table 3. Primers used for bacterial epitope mapping and NGS library generation

Cloning overhang sequences are indicated in bold. Insert sequence shown in red for exemplary library ssODN encodes for the first 15 a.a

We acknowledge the ETH Zurich D-BSSE Single Cell Unit and the Genomics Facility Basel for excellent support and assistance, in particular I. Nissen, T. Schär, E. Burcklen, T. Horn and C. Beisel. We also would like to thank M.D. Hussherr and G. Camenisch for assistance with animal authorization and experiments.pB33eCPX was a gift from Patrick Daugherty (Addgene plasmid # 23336; http://n2t.net/addgene:23336;